Quantcast

Latest Boehringer Ingelheim Stories

2014-03-11 23:27:48

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Stephan Klaschka, Director, Global Innovation Strategy of Boehringer Ingelheim will be speaking at Pharmica’s “Pharma 3.0 – The Digital Medicine Era” conference to be held April 30th & May 1st, 2014 in Conshohocken, PA. Conshohocken, PA (PRWEB) March 11, 2014 The transition to a services and outcome focus is underway in healthcare. Digital medicine provides the...

2014-03-07 23:25:20

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) March 07, 2014 The prescription drug safety center DrugRisk.com is announcing updated legal news on the site for patients taking the blood thinner Pradaxa. In a new report, lawsuits allege the research institute that conducted trails of Pradaxa for its FDA approval failed to disclose side effects like internal...

2014-03-06 08:30:17

Additional drug-drug interaction data for faldaprevir combined with commonly prescribed HIV medications also presented at CROI 2014 INGELHEIM, Germany and RIDGEFIELD, Conn., March 6, 2014 /PRNewswire/ -- Today Boehringer Ingelheim announced results from STARTVerso(®)4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg...

2014-03-05 23:02:23

The Firm is evaluating Pradaxa lawsuits on behalf of patients who allegedly suffered serious and life-threatening internal bleeding due to Pradaxa. New York, New York (PRWEB) March 05, 2014 As thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) continue to move forward in federal court, Bernstein Liebhard LLP notes that newly unsealed court documents indicate that Boehringer Ingelheim did not inform federal regulators of a data analysis that indicated Pradaxa was...

2014-03-05 23:01:52

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company presenting Llaves para una mejor salud (Keys to a Healthier You) diabetes education pavilion. ACA and Medicaid health insurance pavilion providing one-to-one support. Phoenix, AZ (PRWEB) March 05, 2014 On Saturday, March 8, 2014, the National Alliance for Hispanic Health kicks off the 2014 ¡Vive tu vida! Get Up! Get Moving!® 10-event series in Phoenix, Arizona with local community-based organization partner,...

2014-03-05 12:26:22

Boehringer Ingelheim and Lilly are committed to working with the FDA RIDGEFIELD, Conn. and INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. The complete response letter...

2014-03-01 12:20:30

For U.S. Media Only RIDGEFIELD, Conn., March 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented data from Phase 3 studies of tiotropium delivered via the Respimat(®) inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting in San Diego. Tiotropium is being studied to determine its efficacy and safety in treating asthma patients and is not currently approved for this indication. The first results...

2014-02-27 23:38:29

Bloomberg reported on February 26 that, according to unsealed court filings, Boehringer didn’t share with the FDA an analysis showing a higher death rate from Pradaxa bleeding. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) February 27, 2014 AttorneyOne.com, a recognized authority on law, updated...

2014-02-24 23:03:02

The attorneys at Bernstein Liebhard LLP are evaluating potential Pradaxa lawsuit claims from individuals who may have experienced serious episodes of internal bleeding caused by the anti-coagulant. New York, NY (PRWEB) February 24, 2014 Thousands of recently-filed Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) are alleging that certain researchers and medical institutions may have concealed vital safety data about the blood-thinner in clinical trials that led to its U.S. approval,...

2014-02-20 08:31:52

- Milestone achieved for BI's initiation of Phase 1 study in beta-secretase (BACE) inhibitor program FORT WASHINGTON, Pa., Feb. 20, 2014 /PRNewswire/ -- Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and advancing novel, small molecule, best-in-class compounds, announced today that it has earned a $14 million milestone payment from Boehringer Ingelheim (BI) for BI's initiation of a Phase 1 clinical trial in the companies' beta-secretase...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.